| Total | Reactivation | p valuea | |||
---|---|---|---|---|---|---|
Total (%) | CMV only | EBV only | CMV and EBV | |||
Number of patients | 116 | 54 (47) | 36 | 9 | 9 | Â |
Sex | ||||||
 M | 71 | 30 (42) | 18 | 8 | 4 | 0.26 |
 F | 45 | 24 (53) | 18 | 1 | 5 | |
Median age (range) | 49.8 (17.6–70.6) | 50.7 (17.6–68.5) | 55.7 (28.5–68.5) | 55.8 (17.5–68.3) | 56.8 (23.8–65.8) | 0.43 |
Stemcell source | ||||||
 Cord blood | 1 | 0 (0) | 0 | 0 | 0 | 0.30 |
 Peripheral blood | 106 | 48 (45) | 34 | 6 | 7 | |
 Bone marrow | 9 | 6 (67) | 2 | 3 | 2 | |
Donor | ||||||
 Related | 35 | 13 (37) | 11 | 1 | 2 | 0.23 |
 Unrelated | 81 | 40 (5) | 25 | 8 | 7 | |
 HLA mismatch | 20 | 11 (55) | 7 | 2 | 2 | |
Conditioning | ||||||
 NMA | 106 | 50 (47) | 36 | 6 | 8 | 0.47 |
 MA | 10 | 4 (40) | 0 | 2 | 2 | |
 ATG | 87 | 46 (53) | 28 | 9 | 9 | 0.03 |
EBV serology (R/D) | ||||||
 +/+ | 94 | 42 (45) | 27 | 8 | 7 | 0.84 |
 +/− | 5 | 3 (60) | 1 | 0 | 2 | |
 −/+ | 4 | 2 (50) | 2 | 0 | 0 | |
 −/− | 11 | 6 (54) | 5 | 1 | 0 | |
CMV serology (R/D) | ||||||
 +/+ | 39 | 28 (72) | 24 | 0 | 4 | <10 −4 |
 +/− | 37 | 18 (49) | 10 | 5 | 3 | |
 −/+ | 10 | 2 (20) | 1 | 0 | 1 | |
 −/− | 28 | 5 (18) | 1 | 4 | 0 | |
aGVHD | ||||||
 Yes | 64 | 29 (44) | 17 | 5 | 7 | 0.83 |
 No information | 19 | 9 (47) | 8 | 1 | 0 | |
 Relapse | 14 | 7 (50) | 2 | 0 | 0 | 0.78 |
Viral loadb | ||||||
 Low (<1000 copies/ml) | NA | 28 (52) | 21 | 4 | 3 | NA |
 High (>1000 copies/ml) | NA | 26 (48) | 15 | 5 | 6 |